Open AccessThe pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis
Author(s) -
Samir K. Gupta,
Susan L. Rosenkranz,
Yoninah Cramer,
Susan L. Koletar,
Lynda A. Szczech,
Valerianna Amorosa,
Stephen D. Hall
Publication year - 2008
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32830e011f
Subject(s) - efavirenz , lopinavir , lopinavir/ritonavir , ritonavir , pharmacokinetics , medicine , virology , hemodialysis , pharmacogenomics , human immunodeficiency virus (hiv) , pharmacology , antiretroviral therapy , viral load
To evaluate the pharmacokinetics and pharmacogenomics of efavirenz (EFV) and lopinavir/ritonavir (LPV/RTV) in HIV-infected persons requiring hemodialysis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom